DoubleChecks

What was claimed

If you know someone with cancer, tell them to try Ivermectin, Fenbendazole and Mebendazole. Best part, no serious side effects

Our verdict

Inaccurate

None of these drugs is an established, approved cure for cancer; high‑quality clinical evidence is lacking for fenbendazole and ivermectin, and mebendazole has only limited early‑phase/experimental data. Major cancer authorities and drug regulators do not recommend these drugs for cancer outside controlled clinical trials. ASCO cited a real risk of toxicity and drug interactions with these drugs. Mebendazole may cause side effects such as abdominal pain, headache, diarrhea, fatigue, or anemia. Additionally, in some cases, the concentrations of ivermectin required to achieve antitumor effects in vitro exceed what can be safely achieved in humans, raising additional concerns about feasibility. (Only 2 of 3 AI systems responded.)

All 2 AI systems agreeChecked Jul 27, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

These drugs have no serious side effects.

Incorrect92%
All 2 AIs agree

People with cancer should try ivermectin, fenbendazole and mebendazole as treatments.

Incorrect93%
1 of 2 AIs agree·Claude: Misleading

These are established cancer treatments

Incorrect98%
1 AI checked

Detailed Analysis

Did not respond

What other AI think

The statement makes dangerous medical recommendations that contradict current medical consensus. While some preclinical research exists, there is no established clinical evidence these drugs cure cancer. The claim about "no serious side effects" is factually inaccurate and contradicts both medical literature and regulatory guidance.

Why this verdict

  • The statement makes dangerous medical recommendations that contradict current medical consensus.
  • While some preclinical research exists, there is no established clinical evidence these drugs cure cancer.
  • The claim about "no serious side effects" is factually inaccurate and contradicts both medical literature and regulatory guidance.

Claims checked

These drugs have no serious side effects

Incorrect92%
ASCO cited a real risk of toxicity and drug interactions with these drugs. Mebendazole may cause side effects such as abdominal pain, headache, diarrhea, fatigue, or anemia. Additionally, in some cases, the concentrations of ivermectin required to achieve antitumor effects in vitro exceed what can be safely achieved in humans, raising additional concerns about feasibility.

This claim may mislead readers without added context.

These are established cancer treatments

Incorrect98%
No randomized controlled trial has shown that ivermectin, fenbendazole, or mebendazole cure colorectal cancer in humans. Published peer-reviewed evidence that ivermectin, mebendazole, or fenbendazole work as anticancer treatments in humans is extremely limited: most data are preclinical (cell lines and animal models), a handful of small case reports and compilations exist for benzimidazoles, and formal human trials or randomized controlled data are largely absent or unpublished.

This claim may mislead readers without added context.

Ivermectin, Fenbendazole and Mebendazole should be tried for cancer treatment

Misleading95%
In May 2026, the American Society of Clinical Oncology (ASCO) issued a formal Clinical Notice recommending against using ivermectin or fenbendazole for cancer treatment outside of a registered clinical trial, citing insufficient evidence and a real risk of toxicity and drug interactions. There is currently no high-quality clinical evidence demonstrating that ivermectin is effective as a cancer treatment, with no large randomized controlled trials supporting its use and available data in humans remaining extremely limited. The FDA has never approved fenbendazole for humans for any purpose, and experts agree that scientific data does not exist about whether fenbendazole is safe and effective for people.

This claim may mislead readers without added context.

The statement recommends unproven antiparasitic drugs as cancer treatments and claims they have no serious side effects. Both parts are factually incorrect and potentially dangerous. High-quality sources and regulatory bodies do not support these claims and report safety concerns for off‑label use.

Why this verdict

  • The statement recommends unproven antiparasitic drugs as cancer treatments and claims they have no serious side effects.
  • Both parts are factually incorrect and potentially dangerous.
  • High-quality sources and regulatory bodies do not support these claims and report safety concerns for off‑label use.

Claims checked

These drugs have no serious side effects.

Incorrect92%
Serious adverse effects have been reported with off‑label use: liver injury has been associated with fenbendazole, ivermectin can cause toxicity at high/incorrect doses and has documented adverse events, and mebendazole has known side effects and limited safety data when used long‑term or at repurposing doses. Regulators warn against unsupervised use.

This claim may mislead readers without added context.

People with cancer should try ivermectin, fenbendazole and mebendazole as treatments.

Incorrect93%
None of these drugs is an established, approved cure for cancer; high‑quality clinical evidence is lacking for fenbendazole and ivermectin, and mebendazole has only limited early‑phase/experimental data. Major cancer authorities and drug regulators do not recommend these drugs for cancer outside controlled clinical trials.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks